Trastuzumab and pertuzumab have demonstrated good efficacy for treatment of HER2-positive BC in clinical trials (CLEOPATRA, PUFFIN, NeoSphere, PEONY) [15–18]. The gene discussed is ERBB2; the disease is breast cancer.